Keyphrases
Breast Cancer
100%
Middle East and North Africa
100%
Subtype-specific
100%
Transcriptome Profiling
100%
Therapeutic Molecular Targets
100%
MicroRNA Regulatory Network
100%
Sub-network Enrichment Analysis
100%
Transcriptomic Network
100%
MicroRNA
71%
Tumor
57%
Human Epidermal Growth Factor Receptor 2 (HER2)
57%
Breast Cancer Subtypes
42%
Transcriptomic Data
28%
Gene Regulatory Network
28%
Transcriptome
28%
Transcriptomic Profiling
28%
Qatar
14%
Young Age
14%
Breast Cancer Patients
14%
Africa Region
14%
Putative Drug Targets
14%
Gene Regulation
14%
Cas9 Protein
14%
Functional Screen
14%
Differentially Expressed Genes
14%
Standard of Care
14%
Profile Data
14%
Differentially Expressed mRNAs (DEmRNAs)
14%
Gene Targeting
14%
Therapeutic Vulnerabilities
14%
Relapse-free Survival
14%
Tumor Stage
14%
Tumor Grade
14%
Actionable Genes
14%
Advanced Tumor
14%
Older Patients
14%
Cox Regression
14%
Low-grade Tumor
14%
CD123
14%
Large Breast
14%
Biological Differences
14%
Medicine and Dentistry
Breast Cancer
100%
microRNA
100%
Gene Expression Profiling
100%
Messenger RNA
50%
Tumor
50%
Triple Negative Breast Cancer
37%
Breast Cancer Molecular Subtype
37%
Neoplasm
25%
Transcriptome
25%
Clustered Regularly Interspaced Short Palindromic Repeat
12%
Cancer Staging
12%
Cas9
12%
Gene Control
12%
Recurrence Free Survival
12%
Proportional Hazards Model
12%
Biochemistry, Genetics and Molecular Biology
Gene Expression Profiling
100%
Regulatory Network
100%
MicroRNA
100%
Messenger RNA
66%
Transcriptome
33%
CRISPR/Cas9
16%
Gene Control
16%
Cancer Staging
16%
Recurrence Free Survival
16%
Differentially Expressed Gene
16%
Immunology and Microbiology
Transcriptome
100%
Gene Expression Assay
100%
CRISPR/Cas9
50%
Cancer Staging
50%
Gene Control
50%
Recurrence Free Survival
50%